Jason Fuller

Jason Fuller

Corporate Officer/Principal bij
Massachusetts Institute of Technology
48 jaar
Health Technology
Finance
Consumer Services

Profiel

Jason Fuller, Ph.D., is a Partner on the Therapeutics team and joined the Firm in 2021.
Prior to Deerfield, Dr. Fuller was an investor at New Enterprise Associates (NEA), where he co-managed several investments in therapeutics, as well as in tools and diagnostics.
Previous to NEA, he served as Head of Corporate Development at Jounce Therapeutics, one of several company formation projects he helped initiate in his role as Principal at Third Rock Ventures before joining Jounce.
Dr. Fuller holds a B.S.
in Chemical Engineering from Michigan State University, an M.Phil.
from Cambridge University, and a Ph.D.
in Chemical Engineering from the Massachusetts Institute of Technology, where he completed his degree in the lab of Robert Langer

Actieve functies van Jason Fuller

BedrijvenFunctieBegin
Corporate Officer/Principal 07-04-2011
Private Equity Investor 01-01-2014
Private Equity Investor 01-01-2021

Eerdere bekende functies van Jason Fuller

BedrijvenFunctieEinde
GALERA THERAPEUTICS, INC. Directeur/Bestuurslid 09-06-2020
Directeur/Bestuurslid -
JOUNCE THERAPEUTICS, INC. Oprichter -
SAGIMET BIOSCIENCES INC. Directeur/Bestuurslid -
3M COMPANY Corporate Officer/Principal -
Ervaring van Jason Fuller in detail bekijken

Opleiding van Jason Fuller

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

97

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit12

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Finance

Health Technology

Health Technology

Finance

  1. Beurs
  2. Insiders
  3. Jason Fuller